Does BPA cause Autism?
18
1kṀ1424
resolved Oct 19
Resolved
N/A

A new paper in PLOS One claims to have found a biological mechanism by which a genetic variation causes certain people to be less able to detoxify BPA (and maybe other chemicals), and that the resulting buildup of these chemicals lead to the cluster of correlated neurological differences we know as autism. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0289841

Bisphenol-A and phthalate metabolism in children with neurodevelopmental disorders
Background The etiology of autism spectrum (ASD) and Attention Deficit/Hyperactivity (ADHD) disorders are multifactorial. Epidemiological studies have shown associations with environmental pollutants, such as plasticizers. This study focused on two of these compounds, the Bisphenol-A (BPA) and Diethylhexyl Phthalate (DEHP). The major pathway for BPA and DEHP excretion is via glucuronidation. Glucuronidation makes insoluble substances more water-soluble allowing for their subsequent elimination in urine. Hypothesis Detoxification of these two plasticizers is compromised in children with ASD and ADHD. Consequently, their tissues are more exposed to these two plasticizers. Methods We measured the efficiency of glucuronidation in three groups of children, ASD (n = 66), ADHD (n = 46) and healthy controls (CTR, n = 37). The children were recruited from the clinics of Rutgers-NJ Medical School. A urine specimen was collected from each child. Multiple mass spectrometric analyses including the complete metabolome were determined and used to derive values for the efficiency of glucuronidation for 12 varied glucuronidation pathways including those for BPA and MEHP. Results (1) Both fold differences and metabolome analyses showed that the three groups of children were metabolically different from each other. (2) Of the 12 pathways examined, only the BPA and DEHP pathways discriminated between the three groups. (3) Glucuronidation efficiencies for BPA were reduced by 11% for ASD (p = 0.020) and 17% for ADHD (p<0.001) compared to controls. DEHP showed similar, but not significant trends. Conclusion ASD and ADHD are clinically and metabolically different but share a reduction in the efficiency of detoxification for both BPA and DEHP with the reductions for BPA being statistically significant.

Will this paper stand up to scrutiny for one year, in my judgement? Market resolves YES, in one year, other papers cite this one favorably and there are no convincing debunkings. Resolves NO if the theory is debunked. Resolves N/A if there's basically no further discussion of this alleged finding.

I will not bet in this market.

Get
Ṁ1,000
to start trading!
© Manifold Markets, Inc.TermsPrivacy